Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study
- DOI
- 10.1016/j.breast.2023.05.008
- Published
- 2023-08
- Container
- The Breast
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2023.05.008,
title = {Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study},
author = {Jacob Thurell and Narges Manouchehri and Irma Fredriksson and Ulla Wilking and Jonas Bergh and Lisa Ryden and Linetta B. Koppert and Maria M. Karsten and Narsis A. Kiani and Elham Hedayati},
year = {2023},
journal = {The Breast},
doi = {10.1016/j.breast.2023.05.008},
url = {https://doi.org/10.1016/j.breast.2023.05.008}
}RIS
TY - JOUR TI - Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study AU - Jacob Thurell AU - Narges Manouchehri AU - Irma Fredriksson AU - Ulla Wilking AU - Jonas Bergh AU - Lisa Ryden AU - Linetta B. Koppert AU - Maria M. Karsten AU - Narsis A. Kiani AU - Elham Hedayati PY - 2023 JO - The Breast DO - 10.1016/j.breast.2023.05.008 UR - https://doi.org/10.1016/j.breast.2023.05.008 ER -
APA
Thurell, J., Manouchehri, N., Fredriksson, I., Wilking, U., Bergh, J., Ryden, L., Koppert, L. B., Karsten, M. M., Kiani, N. A., & Hedayati, E. (2023). Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study. The Breast. https://doi.org/10.1016/j.breast.2023.05.008
Source records
- crossref · retrieved 2026-09-26T17:09:13.606Z